tiprankstipranks
Trending News
More News >
Shandong Xinhua Pharmaceutical Company Limited Class H (HK:0719)
:0719

Shandong Xinhua Pharmaceutical Company Limited Class H (0719) Revenue

Compare
2 Followers

Shandong Xinhua Pharmaceutical Company Limited Class H Revenue

Shandong Xinhua Pharmaceutical Company Limited Class H had a revenue of 2.32B in the quarter ending Sep 30, 2025, with 5.05%. This bring the company's revenue in the last twelve months to 8.69B, Decreased 3.81%. In the fiscal year ending Dec 31, 2024, Shandong Xinhua Pharmaceutical Company Limited Class H had annual revenue of 8.47B with 4.51% growth.
Revenue (ttm)
8.69B
Revenue Growth
1.65%
P/S Ratio
1.21
Revenue/Employee
HK$1,160,404
Employees
7,296
Market Cap
HK$10.24B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
8.47B365.47M+104.51%
Dec 31, 2023
8.10B597.86M+107.97%
Dec 31, 2022
7.50B942.91M+114.37%
Dec 31, 2021
6.56B554.49M+109.23%
Dec 31, 2020
6.01B399.57M+107.13%
Dec 31, 2019
5.61B398.15M+107.65%
Dec 31, 2018
5.21B692.15M+115.33%
Dec 31, 2017
4.52B500.75M+112.47%
Dec 31, 2016
4.01B